Biomedical electrode with anti-microbial properties
Inventors
Porter, Justin • Morgan, Gary Chad • Shaw, Anthony • Adams, Jenifer
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
A biomedical electrode for electrically contacting a user's skin includes a carrier layer, a backing layer, an electrical lead, a conductive member, and a gel contact member. The backing layer is disposed on the carrier layer. The electrical lead is positioned at least in part below the carrier layer. The conductive member is coupled to the electrical lead. The gel contact member is electrically coupled to the conductive member for directly contacting the user's skin. The gel contact member is electrically conductive. The gel contact member includes a gel combined with an anti-microbial agent.
Core Innovation
The invention relates to a reusable biomedical electrode for electrically contacting a user’s skin, including a carrier layer, a backing layer disposed on the carrier layer, an electrical lead positioned at least in part below the carrier layer, a conductive member coupled to the electrical lead, and a gel contact member coupled to the conductive member for directly contacting the user’s skin. The gel contact member is electrically conductive and includes a gel combined with an anti-microbial agent.
The gel contact member inhibits the growth of microbes, prevents growth of microbes, or kills microbes under the gel contact member, and provides a zone of inhibition around the electrode having a size greater than the size of the electrode. The zone of inhibition is a zone where microbes are killed, where growth of microbes is inhibited, where growth of microbes is prevented, or a combination thereof.
The gel contact member includes one or more of bacteriostatic and bactericidal properties to prevent the gel contact member from being contaminated so that it may be used multiple times, including preventing growth of microbes and/or killing microbes under the gel contact member and within the gel contact member to permit multiple uses of the electrode.
Claims Coverage
The independent claims in the provided set cover methods of killing, inhibiting growth, or preventing growth of infectious disease-causing microbes in a mammal using a reusable biomedical electrode with a conductive antimicrobial gel contact member that creates a zone of inhibition larger than the electrode. Several claims further specify bacteriostatic/bactericidal properties and quantitative zone-of-inhibition ranges for selected microbes.
Reusable biomedical electrode with conductive antimicrobial gel contact member that forms an inhibition zone larger than the electrode
A reusable biomedical electrode for electrically contacting a user's skin, comprising a carrier layer, a backing layer disposed on the carrier layer, an electrical lead positioned at least in part below the carrier layer, a conductive member coupled to the electrical lead, and a conductive gel contact member directly contacting the user's skin, wherein the gel contact member includes a gel combined with an anti-microbial agent and provides a zone of inhibition around the electrode having a size greater than the size of the electrode.
Bacteriostatic/bactericidal gel contact member configured to permit multiple uses of the reusable electrode
The gel contact member has one or more of bacteriostatic and bactericidal properties to prevent the gel contact member from being contaminated so that it may be used multiple times, and prevents growth of microbes and/or kills microbes under the gel contact member and within the gel contact member to permit multiple uses of the electrode.
Specific affected microbe sets and quantitative zone-of-inhibition ranges
The microbes affected under the electrode are selected from E. cloacae ATCC BAA-2468 (CRE), S. aureus ATCC 33592 (MRSA), E. coli ATCC BAA-196 (ESBL), E. faecalis ATCC 51575 (VRE), P. aeruginosa ATCC BAA-2114 (Multi-Drug Resistant), and A. baumannii ATCC BAA-1605 (Multi-Drug Resistant), and the microbes affected in a zone of inhibition around the electrode are selected from S. aureus ATCC 33592 (MRSA), E. coli ATCC BAA-196 (ESBL), E. faecalis ATCC 51575 (VRE), P. aeruginosa ATCC BAA-2114 (Multi-Drug Resistant), and A. baumannii ATCC BAA-1605 (Multi-Drug Resistant), with claim-specific zone-of-inhibition ranges for each specified microbe.
The claims center on a reusable biomedical electrode with an electrically conductive antimicrobial gel contact member that inhibits, prevents, or kills microbes and provides a zone of inhibition larger than the electrode. The claims also specify bacteriostatic and bactericidal properties for multiple use and include quantitative zone-of-inhibition ranges for selected infectious microbes.
Stated Advantages
Bacteriostatic and bactericidal properties to prevent the gel contact member from being contaminated so that it may be used multiple times.
Multiple uses of the electrode by killing microbes under the gel contact member and within the gel contact member.
A zone of inhibition around the electrode with a size greater than the size of the electrode.
Inhibition, prevention of growth, or killing of microbes under and around the gel contact member and within the gel contact member.
Documented Applications
A reusable biomedical electrode for electrically contacting a user's skin to address microbes that cause infectious disease in a mammal, including specified microbes under and in the zone of inhibition around the electrode.
Interested in licensing this patent?